Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 14, 2026
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 27, 2023
A Review of Scheduling Strategies for Radiotherapy and Immune Checkpoint Inhibition in Locally Advanced Rectal Cancer.
Journal: Journal of immunotherapy and precision oncology
Published: April 26, 2023
Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target.
Journal: Nature metabolism
Published: February 24, 2022
Activation of innate-adaptive immune machinery by poly(I:C) exposes a therapeutic vulnerability to prevent relapse in stroma-rich colon cancer.
Journal: Gut
Published: September 23, 2021
Pre-clinical modelling of rectal cancer to develop novel radiotherapy-based treatment strategies.
Journal: Oncology reviews
Published: August 18, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026